IP Library Patent Application 10880350
Patent Application
App. No. 10/880,350

Methods and compositions for preparing capped RNA

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/880,350
Abstract

The present invention concerns methods and compositions for increasing the yield of capped and full-length RNA transcripts produced in in vitro transcription reactions. Such methods and compositions can be used for cost-efficient, large scale production of capped full-length RNA transcripts that can be subsequently translated. Methods and compositions involve reaction conditions that promote such production, and includes the implementation of fed-batch introduction of GTP, which competes with a cap analog.

Claims (40)

1 . A method for producing capped RNA comprising:

a) incubating components for a transcription and capping reaction under conditions to promote transcription and capping, wherein the components include a cap analog, a nucleotide that competes with the cap analog, and non-competing nucleotides; and,

b) supplementing the reaction with the competing nucleotide to maintain the concentration of the competing nucleotide in the reaction at a ratio between about 1:1 and about 1:50 relative to the concentration of the cap analog in the reaction.

2 . The method of claim 1 , wherein the reaction is supplemented to maintain the concentration of the competing nucleotide in the reaction at a ratio between about 1:4 and about 1:25 relative to the concentration of the cap analog in the reaction.

3 . The method of claim 1 , wherein the reaction is supplemented intermittently by a fed batch process.

4 . The method of claim 1 , wherein the competing nucleotide is GTP or a GTP analog.

5 . The method of claim 1 , wherein the concentration of the cap analog in the reaction is between about 1 mM and about 10 mM.

6 . The method of claim 5 , wherein the concentration of the cap analog in the reaction is between about 2 mM and about 6 mM.

7 . The method of claim 3 , wherein the reaction is supplemented at least two times by the fed-batch process.

8 . The method of claim 1 , wherein the reaction is supplemented with the competing nucleotide to maintain the concentration of the competing nucleotide in the reaction between about 0.1 mM and about 2.0 mM.

9 . The method of claim 3 , wherein each supplementation by the fed-batch process adds between about 0.1 mM and about 2.0 mM of the competing nucleotide to the reaction.

10 . The method of claim 9 , wherein each supplementation by the fed-batch process adds between about 0.2 mM and about 1 mM of the competing nucleotide to the reaction.

11 . The method of claim 1 , wherein the reaction is supplemented with other components of the reaction but not all components of the reaction.

12 . The method of claim 1 , wherein the reaction yields between about 1 mg/ml and about 10 mg/ml of capped transcript.

13 . The method of claim 12 , wherein the reaction yields between about 4 and about 7 mg/ml of capped transcript.

14 . The method of claim 3 , wherein the supplementation is periodic.

15 . The method of claim 1 , wherein the supplementation is continuous during most of the reaction.

16 . The method of claim 15 , wherein the supplementation of the competing nucleotide is at a rate of about 10 μM per minute to about 200 μM per minute.

17 . A method for producing capped RNA comprising introducing to a transcription and capping reaction GTP or a GTP analog by a fed-batch process.

18 . The method of claim 17 , wherein other reaction components, except a cap analog, are introduced to the reaction by the fed-batch process.

19 . The method of claim 17 , wherein the concentration of GTP introduced into the reaction depends on the initial concentration of a cap analog in the reaction.

20 . The method of claim 19 , wherein the concentration of GTP introduced into the reaction is determined based on a ratio of the concentration of GTP to the concentration of the cap analog, wherein the ratio is between about 1:1 and about 1:50.

21 . (canceled)

22 . The method of claim 17 , wherein the amount of GTP or a GTP analog introduced in the reaction by the fed-batch process increases the concentration of GTP or GTP analog in the reaction by less than about 4 mM after each introduction.

23 - 24 . (canceled)

25 . The method of claim 17 , wherein the initial concentration of a cap analog in the reaction is between about 1 mM and about 10 mM.

26 - 30 . (canceled)

31 . The method of claim 17 , wherein the cap analog is selected from the group consisting of m7GpppG; m7GpppA; m7GpppC; GpppG; m2,7GpppG; m2,2,7GpppG; m7Gpppm7G; ARCA; and, m7,2′OmeGpppG, m72′dGpppG, m7,3′OmeGpppG, m7,3′dGpppG and their tetraphosphate derivatives.

32 - 33 . (canceled)

34 . The method of claim 17 , wherein the initial reaction volume is at least about 100 μl.

35 - 37 . (canceled)

38 . The method of claim 17 , wherein one or more of the following components is also introduced by the fed-batch process: polymerase, pyrophosphatase, a magnesium salt, or a ribonuclease inhibitor.

39 . The method of claim 17 , wherein GTP or a GTP analog are introduced into the reaction by a fed-batch process so as to maintain the concentration of GTP or a GTP analog in the reaction less than about 1 mM.

40 . The method of claim 17 , wherein introduction of GTP or a GTP analog by the fed-batch process is intermittent or periodic.

41 - 46 . (canceled)

47 . The method of claim 17 , wherein one of more reaction components are immobilized.

48 . The method of claim 47 , wherein template is immobilized.

49 - 60 . (canceled)

61 . A method for producing transcripts with a nonextending nucleotide at the 5′ end comprising introducing a nucleotide that competes with the nonextending nucleotide by a fed-batch process to a transcription reaction comprising RNA polymerase and the non-extending nucleotide.

62 - 65 . (canceled)

Assignments (6)
DECLARATION TO CORRECT AN ERROR MADE IN A PREVIOUSLY RECORDED DOCUMENTS THAT ERROREOUSLY AFFECTS THE IDENTIFIED APPLICATIONS AND PATENTS Recorded Sep 8, 2010
From: APPLIED BIOSYSTEMS, LLC
To: ASURAGEN, INC.
Reel/Frame 024964/0156 →
CHANGE OF NAME Recorded Feb 26, 2010
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023994/0538 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023994/0587 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2007
From: APPLERA CORPORATION, THROUGH ITS APPLIED BIOSYSTEMS GROUP
To: ASURAGEN, INC.
Reel/Frame 019965/0098 →
REDACED AGREEMENT AND PLAN OF MERGER DOCUMENT Recorded Apr 26, 2007
From: AMBION, INC.
To: APPLERA CORPORATION
Reel/Frame 019215/0576 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2004
From: LABOURIER, EMMANUEL; PASLOSKE, BRITTAN L.
To: AMBION, INC.
Reel/Frame 016099/0701 →